Variant · Snv
JAK3 NM_000215.4(JAK3):c.1254+20G>A
CI-VAR-00196413Explore in graph →NM_000215.4:c.1254+20G>AClinVar 1167464 rs3212742
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1167464 | Benign | criteria provided, multiple submitters, no conflicts | 2 | T-B+ severe combined immunodeficiency due to JAK3 deficiency; Thymoma; Lung cancer; Acute myeloid leukemia; Cervical cancer; Uterine corpus endometrial carcinoma; Gastric cancer | germline | 3 | Feb 04, 2026 | clinvar |